- Home
- Publications
Publications
"Antineoplastics for treating Alzheimer's disease and dementia: Evidence from preclinical and observational studies",
MEDICINAL RESEARCH REVIEWS, vol. 44, iss. 5, pp. 2078-2111, 2024.
IF = 11.6
MEDICINAL RESEARCH REVIEWS, vol. 44, iss. 5, pp. 2078-2111, 2024.
IF = 11.6
CATRIN-IMTM
DOI: 10.1002/med.22033
"Novel dimeric dual-modality FAP-targeted agents with favorable tumor retention for image-guided surgery: a preclinical study",
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, vol. 53, iss. 4, pp. 2578-2591, 2026.
IF = 7.6
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, vol. 53, iss. 4, pp. 2578-2591, 2026.
IF = 7.6
CATRIN-IMTM
DOI: 10.1007/s00259-025-07626-z
"PET/CT imaging of esophageal cancer targeting tumor cell specific αvβ6-integrin expression",
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, vol. 53, iss. 1, pp. 607-618, 2025.
IF = 7.6
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, vol. 53, iss. 1, pp. 607-618, 2025.
IF = 7.6
CATRIN-IMTM
DOI: 10.1007/s00259-025-07408-7
"Engineering PD-1-targeted small protein variants for in vitro diagnostics and in vivo PET imaging",
JOURNAL OF TRANSLATIONAL MEDICINE, vol. 22, iss. 1, article no. 426, 2024.
IF = 7.5
JOURNAL OF TRANSLATIONAL MEDICINE, vol. 22, iss. 1, article no. 426, 2024.
IF = 7.5
CATRIN-IMTM
DOI: 10.1186/s12967-024-05210-x
"Oncology drug repurposing as a blueprint for Alzheimer's therapy",
ALZHEIMER'S & DEMENTIA: TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, vol. 12, iss. 1, article no. e70231, 2026.
IF = 7.4
ALZHEIMER'S & DEMENTIA: TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, vol. 12, iss. 1, article no. e70231, 2026.
IF = 7.4
CATRIN-IMTM
DOI: 10.1002/trc2.70231
"Diethyldithiocarbamate-copper complex ignites the tumor microenvironment through NKG2D-NKG2DL axis",
FRONTIERS IN IMMUNOLOGY, vol. 16, pp., 2025.
IF = 7
FRONTIERS IN IMMUNOLOGY, vol. 16, pp., 2025.
IF = 7
CATRIN-IMTM
DOI: 10.3389/fimmu.2025.1491450
"“Keep on ROCKIn”: Repurposed ROCK inhibitors to boost corneal endothelial regeneration",
BIOMEDICINE & PHARMACOTHERAPY, vol. 174, pp. 116435, 2024.
IF = 6.9
BIOMEDICINE & PHARMACOTHERAPY, vol. 174, pp. 116435, 2024.
IF = 6.9
CATRIN-IMTM
DOI: 10.1016/j.biopha.2024.116435
"Biomimetic Analogues of the Desferrioxamine E Siderophore for PET Imaging of Invasive Aspergillosis: Targeting Properties and Species Specificity",
JOURNAL OF MEDICINAL CHEMISTRY, vol. 67, iss. 14, pp. 12143-12154, 2024.
IF = 6.8
JOURNAL OF MEDICINAL CHEMISTRY, vol. 67, iss. 14, pp. 12143-12154, 2024.
IF = 6.8
CATRIN-IMTM
DOI: 10.1021/acs.jmedchem.4c00887
"Computational Design of Pore-Forming Peptides with Potent Antimicrobial and Anticancer Activities",
JOURNAL OF MEDICINAL CHEMISTRY, vol. 67, iss. 16, pp. 14040-14061, 2024.
IF = 6.8
JOURNAL OF MEDICINAL CHEMISTRY, vol. 67, iss. 16, pp. 14040-14061, 2024.
IF = 6.8
CATRIN-IMTM
DOI: 10.1021/acs.jmedchem.4c00912
"Repurposing carboplatin-based Pt(IV)-deferoxamine conjugates for infection theranostics",
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, vol. 301, pp. 118216, 2026.
IF = 6.7
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, vol. 301, pp. 118216, 2026.
IF = 6.7
CATRIN-IMTM
DOI: 10.1016/j.ejmech.2025.118216
"Group-based learning on label-free phase-contrast images across dose and exposure time improves bioactive compound classification",
MACHINE LEARNING WITH APPLICATIONS, vol. 24, pp. 100867, 2026.
IF = 6.1
MACHINE LEARNING WITH APPLICATIONS, vol. 24, pp. 100867, 2026.
IF = 6.1
CATRIN-IMTM
DOI: 10.1016/j.mlwa.2026.100867
"Design, synthesis, and biological evaluation of novel 3-oxo-2,3-dihydropyridazine derivatives as interleukin-2-inducible T-cell kinase (ITK) inhibitors",
RSC ADVANCES, vol. 15, iss. 55, pp. 47565-47586, 2025.
IF = 6.1
RSC ADVANCES, vol. 15, iss. 55, pp. 47565-47586, 2025.
IF = 6.1
CATRIN-IMTM
DOI: 10.1039/d5ra06565h
"Optimization of Azaspirooxindolinone-based PROTACs targeting BTK: Synthesis, kinase profiling, and degradation analysis",
RESULTS IN CHEMISTRY, vol. 23, pp. 103145, 2026.
IF = 5.8
RESULTS IN CHEMISTRY, vol. 23, pp. 103145, 2026.
IF = 5.8
CATRIN-IMTM
DOI: 10.1016/j.rechem.2026.103145
"CRISPR/Cas9 bioluminescence-based assay for monitoring CFTR trafficking to the plasma membrane",
LIFE SCIENCE ALLIANCE, vol. 7, iss. 1, pp. e202302045, 2024.
IF = 5.781
LIFE SCIENCE ALLIANCE, vol. 7, iss. 1, pp. e202302045, 2024.
IF = 5.781
CATRIN-IMTM
DOI: 10.26508/lsa.202302045
"New Derivatives of Caracasine Acid with Anti-Leukemic Activity and Limited Effectiveness in Spheroid Cultures",
PHARMACEUTICALS, vol. 18, iss. 7, pp. 1043, 2025.
IF = 5.7
PHARMACEUTICALS, vol. 18, iss. 7, pp. 1043, 2025.
IF = 5.7
CATRIN-IMTM
DOI: 10.3390/ph18071043
"Exploring How Adipose Tissue, Obesity, and Gender Influence the Immune Response to Vaccines: A Comprehensive Narrative Review",
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol. 26, iss. 2, pp. 862, 2025.
IF = 5.6
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol. 26, iss. 2, pp. 862, 2025.
IF = 5.6
CATRIN-IMTM
DOI: 10.3390/ijms26020862
"Exploring the Immunological Aspects and Treatments of Recurrent Pregnancy Loss and Recurrent Implantation Failure",
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol. 26, iss. 3, pp. 1295, 2025.
IF = 5.6
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol. 26, iss. 3, pp. 1295, 2025.
IF = 5.6
CATRIN-IMTM
DOI: 10.3390/ijms26031295
"A Rapid Approach for Identifying Cell Lines Lacking Functional Cytidine Deaminase",
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol. 26, iss. 7, pp. 3344, 2025.
IF = 5.6
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol. 26, iss. 7, pp. 3344, 2025.
IF = 5.6
CATRIN-IMTM
DOI: 10.3390/ijms26073344